InsidersTradesSigma
Follow the 恩华药业 stock price and the full directors' dealings record of the company, a listed issuer based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 恩华药业 has recorded 2 public disclosures. Market capitalisation: €21.8bn. The latest transaction was disclosed on 22 April 2026 (Purchase). Among the most active insiders: 孙彭生. Every trade is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
恩华药业 es una empresa especializada en el sector de la salud y farmacéutico, que ofrece una gama de productos farmacéuticos. Cotiza en el mercado XSHE.